Effectiveness of tranexamic acid on blood loss in patients undergoing elective cesarean section: randomized clinical trial. (새로운 창 열기)

Abdel-Aleem H, Alhusaini TK, Abdel-Aleem MA, Menoufy M, Gülmezoglu AM.

Source‎: J Matern Fetal Neonatal Med 2013;26(17):1705-9.

Indexed‎: PubMed 23574458

https://www.ncbi.nlm.nih.gov/pubmed/23574458 (새로운 창 열기)

Effect of treatment delay on the effectiveness and safety of antifibrinolytics in acute severe haemorrhage: a meta-analysis of individual patient-level data from 40 138 bleeding patients. (새로운 창 열기)

Gayet-Ageron A, Prieto-Merino D, Ker K, Shakur H, Ageron FX, Roberts I; Antifibrinolytic Trials Collaboration

Source‎: Lancet 2018;391(10116):125-32.

Indexed‎: PubMed 29126600

DOI‎: 10.1016/S0140-6736(17)32455-8

https://www.ncbi.nlm.nih.gov/pubmed/29126600 (새로운 창 열기)

Can intravenous injection of tranexamic acid be used in routine practice with active management of the third stage of labor in vaginal delivery? A randomized controlled study. (새로운 창 열기)

Gungorduk K, Asıcıoğlu O, Yıldırım G, Ark C, Tekirdağ Aİ, Besımoglu B.

Source‎: Am J Perinatol 2013;30(5):407-13.

Indexed‎: PubMed 23023559

DOI‎: 10.1055/s-0032-1326986

https://www.ncbi.nlm.nih.gov/pubmed/23023559 (새로운 창 열기)

Efficacy of intravenous tranexamic acid in reducing blood loss after elective cesarean section: a prospective, randomized, double-blind, placebo-controlled study. (새로운 창 열기)

Gungorduk K, Yıldırım G, Asıcıoğlu O, Gungorduk OC, Sudolmus S, Ark C.

Source‎: Am J Perinatol 2011;28(3):233-40.

Indexed‎: PubMed 20979013

https://www.ncbi.nlm.nih.gov/pubmed/20979013 (새로운 창 열기)

Effect of early tranexamic acid administration on mortality, hysterectomy, and other morbidities in women with post-partum haemorrhage (WOMAN): an international, randomised, double-blind, placebo-controlled trial. (새로운 창 열기)

Shakur S, Roberts I, Fawole B, Chaudhri R, El-Sheikh M, et al.; WOMAN Trial Collaborators

Source‎: Lancet 2017;389(10084):2105-16.

Indexed‎: PubMed 28456509

DOI‎: 10.1016/S0140-6736(17)30638-4

https://www.ncbi.nlm.nih.gov/pubmed/28456509 (새로운 창 열기)

Tranexamic acid for preventing postpartum blood loss after cesarean delivery: a systematic review and meta-analysis of randomized controlled trials. (새로운 창 열기)

Simonazzi G, Bisulli M, Saccone G, Moro E, Marshall A, Berghella V.

Source‎: Acta Obstet Gynecol Scand 2016;95(1):28-37.

Indexed‎: PubMed 26698831

DOI‎: 10.1111/aogs.12798

https://www.ncbi.nlm.nih.gov/pubmed/26698831 (새로운 창 열기)

Randomized controlled trial of tranexamic acid among parturients at increased risk for postpartum hemorrhage undergoing cesarean delivery. (새로운 창 열기)

Sujata N, Tobin R, Kaur R, Aneja A, Khanna M, Hanjoora VM.

Source‎: Int J Gynaecol Obstet 2016;133(3):312-5.

Indexed‎: PubMed 26952346

DOI‎: 10.1016/j.ijgo.2015.09.032

https://www.ncbi.nlm.nih.gov/pubmed/26952346 (새로운 창 열기)

Use of recombinant activated factor VII in primary postpartum hemorrhage: the Northern European registry 2000-2004. (새로운 창 열기)

Alfirevic Z, Elbourne D, Pavord S, Bolte A, Van Geijn H, Mercier F, Ahonen J, Bremme K, Bødker B, Magnúsdóttir EM, Salvesen K, Prendiville W, Truesdale A, Clemens F, Piercy D, Gyte G.

Source‎: Obstet Gynecol 2007;110(6):1270-8.

Indexed‎: PubMed 18055720

DOI‎: 10.1097/01.AOG.0000288515.48066.99

https://www.ncbi.nlm.nih.gov/pubmed/18055720 (새로운 창 열기)

The use of recombinant activated FVII in postpartum hemorrhage. (새로운 창 열기)

Franchini M, Franchi M, Bergamini V, Montagnana M, Salvagno GL, Targher G, Lippi G.

Source‎: Clin Obstet Gynecol 2010;53(1):219-27.

Indexed‎: PubMed 20142658

DOI‎: 10.1097/GRF.0b013e3181cc4378

https://www.ncbi.nlm.nih.gov/pubmed/20142658 (새로운 창 열기)

Recombinant human factor VIIa prevents hysterectomy in severe postpartum hemorrhage: single center study. (새로운 창 열기)

Huber AW, Raio L, Alberio L, Ghezzi F, Surbek DV.

Source‎: J Perinat Med 2011;40(1):43-9.

Indexed‎: PubMed 22017328

DOI‎: 10.1515/JPM.2011.109

https://www.ncbi.nlm.nih.gov/pubmed/22017328 (새로운 창 열기)

Postpartum hemorrhage: when uterotonics and sutures fail. (새로운 창 열기)

James AH, McLintock C, Lockhart E.

Source‎: Am J Hematol 2012;87 Suppl 1:S16-22.

Indexed‎: PubMed 22430921

DOI‎: 10.1002/ajh.23156

https://www.ncbi.nlm.nih.gov/pubmed/22430921 (새로운 창 열기)

Recombinant activated factor VII (rFVIIa/NovoSeven®) in the management of severe postpartum haemorrhage: initial report of a multicentre case series in Japan. (새로운 창 열기)

Kobayashi T, Nakabayashi M, Yoshioka A, Maeda M, Ikenoue T.

Source‎: Int J Hematol 2012;95(1):57-63.

Indexed‎: PubMed 22160834

DOI‎: 10.1007/s12185-011-0974-9

https://www.ncbi.nlm.nih.gov/pubmed/22160834 (새로운 창 열기)

Recombinant human FVIIa for reducing the need for invasive second-line therapies in severe refractory postpartum hemorrhage: a multicenter, randomized, open controlled trial. (새로운 창 열기)

Lavigne-Lissalde G, Aya AG, Mercier FJ, Roger-Christoph S, Chauleur C, Morau E, Ducloy-Bouthors AS, Mignon A, Raucoules M, Bongain A, Boehlen F, de Moerloose P, Bouvet S, Fabbro-Peray P, Gris JC.

Source‎: J Thromb Haemost 2015;13(4):520-9.

Indexed‎: PubMed 25594352

DOI‎: 10.1111/jth.12844

https://www.ncbi.nlm.nih.gov/pubmed/25594352 (새로운 창 열기)

Recombinant factor VIIa after amniotic fluid embolism and disseminated intravascular coagulopathy. (새로운 창 열기)

Lim Y, Loo CC, Chia V, Fun W.

Source‎: Int J Gynaecol Obstet 2004;87(2):178-9.

Indexed‎: PubMed 15491576

DOI‎: 10.1016/j.ijgo.2004.08.007

https://www.ncbi.nlm.nih.gov/pubmed/15491576 (새로운 창 열기)

Successful treatment of severe intra-abdominal bleeding associated with disseminated intravascular coagulation using recombinant activated factor VII. (새로운 창 열기)

Moscardó F, Pérez F, de la Rubia J, Balerdi B, Lorenzo JI, Senent ML, Aznar I, Carceller S, Sanz MA.

Source‎: Br J Haematol 2001;114(1):174-6.

Indexed‎: PubMed 11472364

https://www.ncbi.nlm.nih.gov/pubmed/11472364 (새로운 창 열기)

Successful management by recombinant activated factor VII in a case of disseminated intravascular coagulopathy caused by obstetric hemorrhage. (새로운 창 열기)

Nohira T, Osakabe Y, Suda S, Takahashi C, Tanaka A, Ikeda K, Ikeda T, Okabe K.

Source‎: J Obstet Gynaecol Res 2008;34(4 Pt 2):623-30.

Indexed‎: PubMed 18840167

https://www.ncbi.nlm.nih.gov/pubmed/18840167 (새로운 창 열기)

Recombinant factor VIIa as last-resort treatment of desperate haemorrhage. (새로운 창 열기)

Palmason R, Vidarsson B, Sigvaldason K, Ingimarsson JP, Gudbjartsson T, Sigurdsson GH, Onundarson PT.

Source‎: Acta Anaesthesiol Scand 2012;56(5):636-44.

Indexed‎: PubMed 22489992

DOI‎: 10.1111/j.1399-6576.2012.02688.x

https://www.ncbi.nlm.nih.gov/pubmed/22489992 (새로운 창 열기)

Factor VIIa in puerperal hemorrhage with disseminated intravascular coagulation. (새로운 창 열기)

Pepas LP, Arif-Adib M, Kadir RA.

Source‎: Obstet Gynecol 2006;108(3 Pt 2):757-61.

Indexed‎: PubMed 17018493

DOI‎: 10.1097/01.AOG.0000197064.44340.d4

https://www.ncbi.nlm.nih.gov/pubmed/17018493 (새로운 창 열기)

Recombinant activated factor VII in obstetric hemorrhage: experiences from the Australian and New Zealand Haemostasis Registry. (새로운 창 열기)

Phillips LE, McLintock C, Pollock W, Gatt S, Popham P, Jankelowitz G, Ogle R, Cameron PA; Australian and New Zealand Haemostasis Registry.

Source‎: Anesth Analg 2009;109(6):1908-15.

Indexed‎: PubMed 19923520

DOI‎: 10.1213/ANE.0b013e3181c039e6

https://www.ncbi.nlm.nih.gov/pubmed/19923520 (새로운 창 열기)

Recombinant factor VIIa to successfully manage disseminated intravascular coagulation from amniotic fluid embolism. (새로운 창 열기)

Prosper SC, Goudge CS, Lupo VR.

Source‎: Obstet Gynecol 2007;109(2 Pt2):524-5.

Indexed‎: PubMed 17267882

DOI‎: 10.1097/01.AOG.0000235711.11817.8c

https://www.ncbi.nlm.nih.gov/pubmed/17267882 (새로운 창 열기)

The efficacy of fibrinogen concentrate compared with cryoprecipitate in major obstetric haemorrhage--an observational study. (새로운 창 열기)

Ahmed S, Harrity C, Johnson S, Varadkar S, McMorrow S, Fanning R, Flynn CM, O'Riordan JM, Byrne BM.

Source‎: Transfus Med 2012;22(5):344-9.

Indexed‎: PubMed 22994449

https://www.ncbi.nlm.nih.gov/pubmed/22994449 (새로운 창 열기)

The use of fibrinogen concentrate to correct hypofibrinogenaemia rapidly during obstetric haemorrhage. (새로운 창 열기)

Bell SF, Rayment R, Collins PW, Collis RE.

Source‎: Int J Obstet Anesth 2010;19(2):218-23.

Indexed‎: PubMed 20194010

DOI‎: 10.1016/j.ijoa.2009.08.004

https://www.ncbi.nlm.nih.gov/pubmed/20194010 (새로운 창 열기)

Association between fibrinogen level and severity of postpartum haemorrhage: secondary analysis of a prospective trial. (새로운 창 열기)

Cortet M, Deneux-Tharaux C, Dupont C, Colin C, Rudigoz RC, Bouvier-Colle MH, Huissoud C.

Source‎: Br J Anaesth 2012;108(6):984-9.

Indexed‎: PubMed 22490316

DOI‎: 10.1093/bja/aes096

https://www.ncbi.nlm.nih.gov/pubmed/22490316 (새로운 창 열기)

Association between fibrinogen levels and severity of postpartum hemorrhage in singleton vaginal deliveries at a Japanese perinatal center. (새로운 창 열기)

Shibata Y, Shigemi D, Ito M, Terada K, Nakanishi K, Kato M, Igarashi M, Suzuki S.

Source‎: J Nippon Med Sch 2014;81(2):94-6.

Indexed‎: PubMed 24805095

https://www.ncbi.nlm.nih.gov/pubmed/24805095 (새로운 창 열기)

A systematic review: the use of desmopressin for treatment and prophylaxis of bleeding disorders in pregnancy. (새로운 창 열기)

Trigg DE, Stergiotou I, Peitsidis P, Kadir RA.

Source‎: Haemophilia 2012;18(1):25-33.

Indexed‎: PubMed 21624012

DOI‎: 10.1111/j.1365-2516.2011.02573.x

https://www.ncbi.nlm.nih.gov/pubmed/21624012 (새로운 창 열기)

Tisseel for management of traumatic postpartum haemorrhage. (새로운 창 열기)

Dhulkotia JS, Alazzam M, Galimberti A.

Source‎: Arch Gynecol Obstet 2009;279(3):437-9.

Indexed‎: PubMed 18985368

DOI‎: 10.1007/s00404-008-0824-z

https://www.ncbi.nlm.nih.gov/pubmed/18985368 (새로운 창 열기)

Use of FloSeal haemostatic gel in massive obstetric haemorrhage: a case report. (새로운 창 열기)

Moriarty KT, Premila S, Bulmer PJ.

Source‎: BJOG 2008;115(6):793-5.

Indexed‎: PubMed 18355369

DOI‎: 10.1111/j.1471-0528.2007.01654.x

https://www.ncbi.nlm.nih.gov/pubmed/18355369 (새로운 창 열기)

Topical application of recombinant activated factor VII during cesarean delivery for placenta previa. (새로운 창 열기)

Schjoldager BTBG, Mikkelsen E, Lykke MR, Præst J, Hvas AM, Heslet L, Secher NJ, Salvig JD, Uldbjerg N

Source‎: Am J Obstet Gynecol 2017;216(6):608.e1-5.

Indexed‎: PubMed 28219621

DOI‎: 10.1016/j.ajog.2017.02.024

https://www.ncbi.nlm.nih.gov/pubmed/28219621 (새로운 창 열기)

Fibrin sealant for management of complicated obstetric lacerations. (새로운 창 열기)

Whiteside JL, Asif RB, Novello RJ.

Source‎: Obstet Gynecol 2010;115(2 Pt 2):403-4.

Indexed‎: PubMed 20093858

DOI‎: 10.1097/AOG.0b013e3181bb1e28

https://www.ncbi.nlm.nih.gov/pubmed/20093858 (새로운 창 열기)

Role of thromboelastography versus coagulation screen as a safety predictor in pre-eclampsia/eclampsia patients undergoing lower-segment caesarean section in regional anaesthesia. (새로운 창 열기)

Ahmad A, Kohli M, Malik A, Kohli M, Bogra J, Abbas H, Gupta R, Kushwaha BB.

Source‎: J Obstet Gynaecol India 2016;66(Suppl 1):340-6.

Indexed‎: PubMed 27651627

https://www.ncbi.nlm.nih.gov/pubmed/27651627 (새로운 창 열기)

Assessment of coagulation in the obstetric population using ROTEM® thromboelastometry. (새로운 창 열기)

Armstrong S, Fernando R, Ashpole K, Simons R, Columb M.

Source‎: Int J Obstet Anesth 2011;20(4):293-8.

Indexed‎: PubMed 21835606

https://www.ncbi.nlm.nih.gov/pubmed/21835606 (새로운 창 열기)

Obstetric hemorrhage and coagulation: an update. Thromboelastography, thromboelastometry, and conventional coagulation tests in the diagnosis and prediction of postpartum hemorrhage. (새로운 창 열기)

de Lange NM, Lancé MD, de Groot R, Beckers EA, Henskens YM, Scheepers HC.

Source‎: Obstet Gynecol Surv 2012;67(7):426-35.

Indexed‎: PubMed 22926249

DOI‎: 10.1097/OGX.0b013e3182605861

https://www.ncbi.nlm.nih.gov/pubmed/22926249 (새로운 창 열기)

Major obstetric haemorrhage: monitoring with thromboelastography, laboratory analyses or both? (새로운 창 열기)

Karlsson O, Jeppsson A, Hellgren M.

Source‎: Int J Obstet Anesth 2014;23(1):10-7.

Indexed‎: PubMed 24342222

https://www.ncbi.nlm.nih.gov/pubmed/24342222 (새로운 창 열기)

Fibrinogen as a therapeutic target for bleeding: a review of critical levels and replacement therapy. (새로운 창 열기)

Levy JH, Welsby I, Goodnough LT.

Source‎: Transfusion 2014;54(5):1389-405.

Indexed‎: PubMed 24117955

DOI‎: 10.1111/trf.12431

https://www.ncbi.nlm.nih.gov/pubmed/24117955 (새로운 창 열기)

Coagulopathy and placental abruption: changing management with ROTEM-guided fibrinogen concentrate therapy. (새로운 창 열기)

McNamara H, Mallaiah S, Barclay P, Chevannes C, Bhalla A.

Source‎: Int J Obstet Anesth 2015;24(2):174-9.

Indexed‎: PubMed 25659517

https://www.ncbi.nlm.nih.gov/pubmed/25659517 (새로운 창 열기)

Haemostatic monitoring during postpartum haemorrhage and implications for management. (새로운 창 열기)

Solomon C, Collis RE, Collins PW.

Source‎: Br J Anaesth 2012;109(6):851-63.

Indexed‎: PubMed 23075633

DOI‎: 10.1093/bja/aes361

https://www.ncbi.nlm.nih.gov/pubmed/23075633 (새로운 창 열기)